Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2


Authors: 
Touret Franck, Driouich Jean-Sélim, Cochin Maxime, Petit Paul Rémi, Gilles Magali, Barthélémy Karine, Moureau Grégory, Mahon Francois-Xavier, Malvy Denis, Solas Caroline, de Lamballerie Xavier, Nougairède Antoine
Date of publication: 
Wednesday, 1 September, 2021
Volume: 
193
Issue: 
Pages: 
105137
EVAg connections: 
Research funded by EVAg
Published by EVAg partner